Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+T Cell Response

Journal of Immunology - United States
doi 10.4049/jimmunol.1700467
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Multiepitope CD8+ T Cell Response to a NY-ESO-1 Peptide Vaccine Results in Imprecise Tumor Targeting

Journal of Clinical Investigation
Medicine
2002English

A Non-Functional Neoepitope Specific CD8+ T-Cell Response Induced by Tumor Derived Antigen Exposure in Vivo

OncoImmunology
OncologyAllergyImmunology
2018English

MHC-based Detection of Antigen-Specific CD8+ T Cell Responses

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2010English

Persistent Antigen at Vaccination Sites Induces Tumor-Specific CD8+ T Cell Sequestration, Dysfunction and Deletion

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2013English

GTL001, a Bivalent Therapeutic Vaccine Against Human Papillomavirus 16 and 18, Induces Antigen-Specific CD8+ T Cell Responses Leading to Tumor Regression

PLoS ONE
Multidisciplinary
2017English

Postthymic Maturation Influences the CD8 T Cell Response to Antigen

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

TCR Down-Regulation Controls Virus-Specific CD8+ T Cell Responses

Journal of Immunology
AllergyImmunology
2008English

Dynamic Imaging of Experimental Leishmania Donovani-Induced Hepatic Granulomas Detects Kupffer Cell-Restricted Antigen Presentation to Antigen-Specific CD8+ T Cells

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2010English

Specific Mutation of a Gammaherpesvirus-Expressed Antigen in Response to CD8 T Cell Selection in Vivo

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy